Poly- γ -Glutamic acid attenuates angiogenesis and inflammation in experimental colitis

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Davaatseren, Munkhtugs ^a,b   Hwang, Jin Taek ^a   Park, Jae Ho ^a   Kim, Myung Sunny ^a   Wang, Shuaiyu ^c   Sung, Mi Jeong ^a  

^a Korea Food Research Institute   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

^c YELLOW SEA FISHERIES RESEARCH INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; DOCUSATE SODIUM; GLUTAMIC ACID DERIVATIVE; MYELOPEROXIDASE; POLY GAMMA GLUTAMIC ACID; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; POLY(GAMMA-GLUTAMIC ACID); POLYGLUTAMIC ACID; DRUG DERIVATIVE; POLY(GAMMA GLUTAMIC ACID);

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; LEUKOCYTE; MACROPHAGE; MALE; MICROSCOPY; MOUSE; MUCOSA INFLAMMATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEIGHT REDUCTION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; INFLAMMATION; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; TOXICITY; DRUG EFFECT; NEOVASCULARIZATION (PATHOLOGY);

MUS;

ANIMALS; BLOTTING, WESTERN; COLITIS; DEXTRAN SULFATE; FLUORESCENT ANTIBODY TECHNIQUE; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; POLYGLUTAMIC ACID; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; WEIGHT LOSS;

EID: 84878635412     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/982383     Document Type: Article

References (44)

1. Majno G., Chronic inflammation: links with angiogenesis and wound healing. American Journal of Pathology 1998 153 4 1035 1039 2-s2.0-0031688934 (Pubitemid 28465827)
2. Bagli E., Xagorari A., Papetropoulos A., Murphy C., Fotsis T., Angiogenesis in inflammation. Autoimmunity Reviews 2004 3 supplement 1 S26 S27 2-s2.0-16644381772
3. Carmeliet P., Angiogenesis in health and disease. Nature Medicine 2003 9 6 653 660 (Pubitemid 36749213)
4. Carmeliet P., Angiogenesis in life, disease and medicine. Nature 2005 438 7070 932 936 2-s2.0-30744479430 10.1038/nature04478 (Pubitemid 43093958)
5. Danese S., Fiocchi C., Etiopathogenesis of inflammatory bowel diseases. World Journal of Gastroenterology 2006 12 30 4807 4812 2-s2.0-33748293143 (Pubitemid 44323204)
6. Fiocchi C., Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions. American Journal of Physiology 1997 273 4 G769 G775 2-s2.0-0030783258
7. Danese S., Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow. Current Opinion in Gastroenterology 2007 23 4 384 389 2-s2.0-34249944864 10.1097/MOG.0b013e32810c8de3 (Pubitemid 46878949)
8. Danese S., Dejana E., Fiocchi C., Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. Journal of Immunology 2007 178 10 6017 6022 2-s2.0-34248196591 (Pubitemid 46717378)
9. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risaut W., Nagy A., Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996 380 6573 435 439 2-s2.0-0343920277 10.1038/380435a0 (Pubitemid 26102719)
10. Carmeliet P., Collen D., Molecular analysis of blood vessel formation and disease. American Journal of Physiology 1997 273 5, part 2 H2091 H2104
11. Goebel S., Huang M., Davis W. C., VEGF-A stimulation of leukocyte adhesion to colonic microvascular endothelium: implications for inflammatory bowel disease. American Journal of Physiology 2006 290 4 G648 G654
12. Scaldaferri F., Vetrano S., Sans M., Arena V., Straface G., Stigliano E., Repici A., Sturm A., Malesci A., Panes J., Yla-Herttuala S., Fiocchi C., Danese S., VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gastroenterology 2009 136 2 585 595 2-s2.0-58649111743 10.1053/j.gastro.2008.09.064
13. Danese S., VEGF in inflammatory bowel disease: a master regulator of mucosal immune-driven angiogenesis. Digestive and Liver Disease 2008 40 8 680 683 2-s2.0-45849115786 10.1016/j.dld.2008.02.036
14. Ashiuchi M., Kamei T., Baek D. H., Shin S. Y., Sung M. H., Soda K., Yagi T., Misono H., Isolation of Bacillus subtilis(chungkookjang), a poly- γ -glutamate producer with high genetic competence. Applied Microbiology and Biotechnology 2001 57 5-6 764 769 2-s2.0-0035668671 10.1007/s00253-001-0848-9 (Pubitemid 34028276)
15. Shih I. L., Van Y. T., The production of poly-(γ -glutamic acid) from microorganisms and its various applications. Bioresource Technology 2001 79 3 207 225 2-s2.0-0034946131 10.1016/S0960-8524(01)00074-8 (Pubitemid 32633761)
16. Tae W. K., Tae Y. L., Hyun C. B., Jeong H. H., Yang H. K., Park C., Tae H. K., Chul J. K., Moon H. S., Poo H., Oral administration of high molecular mass poly- γ -glutamate induces NK cell-mediated antitumor immunity. Journal of Immunology 2007 179 2 775 780 2-s2.0-34548759204
17. Uto T., Wang X., Sato K., Haraguchi M., Akagi T., Akashi M., Baba M., Targeting of antigen to dendritic cells with poly(γ -glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity. Journal of Immunology 2007 178 5 2979 2986 2-s2.0-33847344203 (Pubitemid 46333177)
18. Kim S., Yang J. Y., Lee K., Bacillus subtilis-specific poly-gamma-glutamic acid regulates development pathways of naive CD4(1) T cells through antigen presenting cell-dependent and-independent mechanisms. International Immunology 2009 21 8 977 990
19. Lee K., Kim S. H., Yoon H. J., Paik D. J., Kim J. M., Youn J., Bacillus-derived poly- γ -glutamic acid attenuates allergic airway inflammation through a Toll-like receptor-4-dependent pathway in a murine model of asthma. Clinical and Experimental Allergy 2011 41 8 1143 1156 2-s2.0-79960406080 10.1111/j.1365-2222.2011.03792.x
20. Soriano A., Salas A., Salas A., Sans M., Gironella M., Elena M., Anderson D. C., Piqué J. M., Panés J., VCAM-1, but not ICAM-1 or MAdCAM-1, immunoblockade ameliorates DSS-induced colitis in mice. Laboratory Investigation 2000 80 10 1541 1551 2-s2.0-0033783628
21. Egger B., Bajaj-Elliott M., Macdonald T. T., Inglin R., Eysselein V. E., Büchler M. W., Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 2000 62 4 240 248 2-s2.0-0033768784
22. Dieleman L. A., Pena A. S., Meuwissen S. G. M., Van Rees E. P., Role of animal models for the pathogenesis and treatment of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 1997 223 99 104 2-s2.0-0030624779 (Pubitemid 27272612)
23. Sasaki M., Bharwani S., Jordan P., Elrod J. W., Grisham M. B., Jackson T. H., Lefer D. J., Alexander J. S., Increased disease activity in eNOS-deficient mice in experimental colitis. Free Radical Biology and Medicine 2003 35 12 1679 1687 2-s2.0-0346996626 10.1016/j.freeradbiomed.2003.09.016 (Pubitemid 37532917)
24. Sasaki M., Bharwani S., Jordan P., Joh T., Manas K., Warren A., Harada H., Carter P., Elrod J. W., Wolcott M., Grisham M. B., Alexander J. S., The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis. Journal of Pharmacology and Experimental Therapeutics 2003 305 1 78 85 2-s2.0-0037382469 10.1124/jpet.102.044099 (Pubitemid 36373837)
25. Sasaki M., Mathis J. M., Jennings M. H., Reversal of experimental colitis disease activity in mice following administration of an adenoviral IL-10 vector. Journal of Inflammation 2005 174 2 992 1002
26. Horino J., Fujimoto M., Terabe F., Serada S., Takahashi T., Soma Y., Tanaka K., Chinen T., Yoshimura A., Nomura S., Kawase I., Hayashi N., Kishimoto T., Naka T., Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice. International Immunology 2008 20 6 753 762 2-s2.0-44849121674 10.1093/intimm/dxn033 (Pubitemid 351791519)
27. Cooper H. S., Murthy S. N. S., Shah R. S., Sedergran D. J., Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Laboratory Investigation 1993 69 2 238 250 2-s2.0-0027224059 (Pubitemid 23262505)
28. Smith J. W., Castro G. A., Relation of peroxidase activity in gut mucosa to inflammation. American Journal of Physiology 1978 234 1 R72 R79 (Pubitemid 9133199)
29. Szekanecz Z., Koch A. E., Vascular endothelium and immune responses: implications for inflammation and angiogenesis. Rheumatic Disease Clinics of North America 2004 30 1 97 114 2-s2.0-1242317779 10.1016/S0889-857X(03)00116-9 (Pubitemid 38234770)
30. Jackson J. R., Seed M. P., Kircher C. H., Willoughby D. A., Winkler J. D., The codependence of angiogenesis and chronic inflammation. The FASEB Journal 1997 11 6 457 465 2-s2.0-0030973217 (Pubitemid 27259987)
31. Danese S., Sans M., de la Motte C., Graziani C., West G., Phillips M. H., Pola R., Rutella S., Willis J., Gasbarrini A., Fiocchi C., Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 2006 130 7 2060 2073 2-s2.0-33744510694 10.1053/j.gastro.2006.03.054 (Pubitemid 43816964)
32. Danese S., Sans M., Spencer D. M., Beck I., Doñate F., Plunkett M. L., De La Motte C., Redline R., Shaw D. E., Levine A. D., Mazar A. P., Fiocchi C., Angiogenesis blockade as a new therapeutic approach to experimental colitis. Gut 2007 56 6 855 862 2-s2.0-34249801207 10.1136/gut.2006.114314 (Pubitemid 46854204)
33. Blumberg R. S., Saubermann L. J., Strober W., Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Current Opinion in Immunology 1999 11 6 648 656 2-s2.0-0032707898 10.1016/S0952-7915(99) 00032-1
34. Chidlow J. H. Jr., Langston W., Greer J. J. M., Ostanin D., Abdelbaqi M., Houghton J., Senthilkumar A., Shukla D., Mazar A. P., Grisham M. B., Kevil C. G., Differential angiogenic regulation of experimental colitis. American Journal of Pathology 2006 169 6 2014 2030 2-s2.0-34249822849 10.2353/ajpath.2006.051021 (Pubitemid 351181962)
35. Fiedler U., Augustin H. G., Angiopoietins: a link between angiogenesis and inflammation. Trends in Immunology 2006 27 12 552 558 2-s2.0-33751225092 10.1016/j.it.2006.10.004 (Pubitemid 44780853)
36. Benelli R., Albini A., Noonan D., Neutrophils and angiogenesis: potential initiators of the angiogenic cascade. Chemical Immunology and Allergy 2003 83 167 181 2-s2.0-0141688295 (Pubitemid 37522417)
37. Benelli R., Lorusso G., Albini A., Noonan D. M., Cytokines and chemokines as regulators of angiogenesis in health and disease. Current Pharmaceutical Design 2006 12 24 3101 3115 2-s2.0-33747152779 10.2174/138161206777947461 (Pubitemid 44227572)
38. Nozawa H., Chiu C., Hanahan D., Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America 2006 103 33 12493 12498 2-s2.0-33747602354 10.1073/pnas.0601807103 (Pubitemid 44267286)
39. Bao P., Kodra A., Tomic-Canic M., Golinko M. S., Ehrlich H. P., Brem H., The role of vascular endothelial growth factor in wound healing. Journal of Surgical Research 2009 153 2 347 358 2-s2.0-64849116779 10.1016/j.jss.2008.04. 023
40. Takahashi H., Shibuya M., The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clinical Science 2005 109 3 227 241 2-s2.0-25144511910 10.1042/CS20040370 (Pubitemid 41337127)
41. Dvorak H. F., Detmar M., Claffey K. P., Nagy J. A., Van de Water L., Senger D. R., Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. International Archives of Allergy and Immunology 1995 107 1-3 233 235 2-s2.0-0029047695
42. Lee Y. C., The involvement of VEGF in endothelial permeability: a target for anti-inflammatory therapy. Current Opinion in Investigational Drugs 2005 6 11 1124 1130 (Pubitemid 41701182)
43. Roy H., Bhardwaj S., Ylä-Herttuala S., Biology of vascular endothelial growth factors. FEBS Letters 2006 580 12 2879 2887 2-s2.0-33646569993 10.1016/j.febslet.2006.03.087 (Pubitemid 43729175)
44. Yamazaki Y., Morita T., Molecular and functional diversity of vascular endothelial growth factors. Molecular Diversity 2006 10 4 515 527 2-s2.0-33845362881 10.1007/s11030-006-9027-3 (Pubitemid 44885229)